Standards Development
Tuberculosis is a deadly disease that not only sickens or kills millions every year in low-income countries, but continues to threaten populations in high-income countries with multi-drug resistant strains. The FDA highlighted TB in its guidance on neglected tropical diseases and joined other stakeholders in accelerating drug development through the Critical Path Institute (C-Path). CPTR... Read more »